AstraZeneca's short shelf life makes Covid vaccine rollout difficult to world's poorest
The relatively short shelf life of AstraZeneca Plc's (AZN.L) Covid -19 vaccine is complicating the rollout to the world's poorest nations, according to officials and internal World Health Organization documents reviewed by Reuters.